Julie Schmittdiel to Follow-Up Studies
This is a "connection" page, showing publications Julie Schmittdiel has written about Follow-Up Studies.
Connection Strength
0.241
-
Initial persistence with antihypertensive therapies is associated with depression treatment persistence, but not depression. J Clin Hypertens (Greenwich). 2014 Jun; 16(6):412-7.
Score: 0.092
-
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California. JAMA Intern Med. 2021 07 01; 181(7):997-1000.
Score: 0.038
-
Medication Adherence Does Not Explain Black-White Differences in Cardiometabolic Risk Factor Control among Insured Patients with Diabetes. J Gen Intern Med. 2016 Feb; 31(2):188-195.
Score: 0.026
-
Pre-Visit Prioritization for complex patients with diabetes: Randomized trial design and implementation within an integrated health care system. Contemp Clin Trials. 2016 Mar; 47:196-201.
Score: 0.026
-
Characteristics of diabetic patients associated with achieving and maintaining blood pressure targets in the Adherence and Intensification of Medications program. Chronic Illn. 2014 Mar; 10(1):60-73.
Score: 0.022
-
Improving blood pressure control through a clinical pharmacist outreach program in patients with diabetes mellitus in 2 high-performing health systems: the adherence and intensification of medications cluster randomized, controlled pragmatic trial. Circulation. 2012 Jun 12; 125(23):2863-72.
Score: 0.020
-
Trends in time to confirmation and recognition of new-onset hypertension, 2002-2006. Hypertension. 2010 Oct; 56(4):605-11.
Score: 0.018